Japan Tissue Engineering Co., Ltd.
Research Japan Tissue Engineering Co., Ltd. (7774.T) on Bullrun: market cap JPY 31.51B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7774.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 31.51B
- Financial periodFY2026
- RevenueJPY 2.18B
- Revenue growth-11.1%
- Net income-JPY 734.75M
- Free cash flow-JPY 565.72M
- Gross margin58.1%
Valuation Snapshot
latest market cap is JPY 31.51B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 2.18B | -JPY 734.75M | -JPY 565.72M | 58.1% | -18.09 | JPY 3.25B | n/a | JPY 5.09B |
| FY2025 | JPY 2.46B | -JPY 255.30M | -JPY 242.24M | 61.5% | -6.29 | JPY 3.89B | n/a | JPY 5.83B |
| FY2024 | JPY 2.51B | JPY 143.17M | JPY 938.00K | 67.2% | 3.53 | JPY 4.27B | JPY 0 | JPY 6.08B |
| FY2023 | JPY 2.03B | -JPY 729.32M | -JPY 798.60M | 55.9% | -17.96 | JPY 4.13B | JPY 133.00K | JPY 5.94B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 31.51B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Contract, and Lab Site Project segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it offers EPI-MODEL, a reconstructed human epidermis model.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Japan Tissue Engineering Co., Ltd.'s market cap?
Japan Tissue Engineering Co., Ltd.'s market capitalization is JPY 31.51B.
What does Japan Tissue Engineering Co., Ltd. do?
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Contract, and Lab Site Project segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it offers EPI-MODEL, a reconstructed human epidermis model.